Advanced Medical Solutions Grp PLC Total Voting Rights (7172F)

TIDMAMS

RNS Number : 7172F

Advanced Medical Solutions Grp PLC

29 July 2016

29 July 2016

Advanced Medical Solutions Group plc

("AMS" or the "Group")

Total Voting Rights

In accordance with Disclosure and Transparency Rule 5.6.1, the issued share capital of Advanced Medical Solutions Group plc as at 29 July 2016 comprises 210,314,074 ordinary shares of 5p each with voting rights. There are no shares held in treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

   -     Ends - 

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group         Tel: +44 (0) 
  plc                                      1606 545508 
 Chris Meredith, Chief Executive 
  Officer 
  Mary Tavener, Group Finance Director 
 
 Consilium Strategic Communications       Tel: +44 (0) 
                                          20 3709 5700 
 Mary-Jane Elliott / Jonathan 
  Birt / Matthew Neal / Hendrik 
  Thys 
 
 Investec Bank PLC (NOMAD & Broker)       Tel: +44 (0) 
                                          20 7597 5970 
 Gary Clarence / Daniel Adams 
  / Patrick Robb 
 

About Advanced Medical Solutions Group plc

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal(R), LiquiBand(R) and RESORBA(R) as well as supplying under white label.AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 510 employees. For more information please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVREADXNADXKEFF

(END) Dow Jones Newswires

July 29, 2016 09:40 ET (13:40 GMT)